| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH8 MYH11 HYOU1 IPO8 ATRX ATP8A2 KIF3A ABCA6 SLFN13 DDX18 RECQL5 MACF1 ATP2B1 TOP2B | 1.95e-05 | 614 | 120 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 7.34e-05 | 14 | 120 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH8 ATRX ATP8A2 RAB8B KIF3A RAB8A ABCA6 SLFN13 MTIF2 DDX18 RECQL5 MACF1 ATP2B1 DNM2 | 2.33e-04 | 775 | 120 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | protein domain specific binding | CACNA1C CACNA1D HIF1A REPS1 ATRX GPR37 RAB8B HNRNPM ADAM12 AFAP1 KCNAB1 DMD ATP2B1 DNM2 PROX1 | 2.42e-04 | 875 | 120 | 15 | GO:0019904 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.04e-04 | 151 | 120 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH8 ATRX ATP8A2 KIF3A ABCA6 SLFN13 DDX18 RECQL5 MACF1 ATP2B1 | 3.33e-04 | 441 | 120 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 3.54e-04 | 5 | 120 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH8 ATRX ATP8A2 RAB8B KIF3A RAB8A ABCA6 SLFN13 MTIF2 DDX18 RECQL5 MACF1 ATP2B1 DNM2 | 5.16e-04 | 839 | 120 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH8 ATRX ATP8A2 RAB8B KIF3A RAB8A ABCA6 SLFN13 MTIF2 DDX18 RECQL5 MACF1 ATP2B1 DNM2 | 5.22e-04 | 840 | 120 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH8 ATRX ATP8A2 RAB8B KIF3A RAB8A ABCA6 SLFN13 MTIF2 DDX18 RECQL5 MACF1 ATP2B1 DNM2 | 5.22e-04 | 840 | 120 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | ribosome binding | 7.92e-04 | 120 | 120 | 5 | GO:0043022 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.10e-03 | 129 | 120 | 5 | GO:0005262 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1C CACNA1D MYH8 MYH11 ANK2 ATP8A2 IRAG1 AKAP9 DMD TNNT1 FKBP1B ATP2B1 | 3.84e-06 | 400 | 120 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 5.09e-06 | 217 | 120 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 7.35e-06 | 22 | 120 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1C CACNA1D MYH8 MYH11 ANK2 ATP8A2 IRAG1 AKAP9 COL14A1 DMD TNNT1 FKBP1B ATP2B1 | 1.83e-05 | 547 | 120 | 13 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 2.00e-05 | 28 | 120 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 2.42e-05 | 202 | 120 | 8 | GO:0006937 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.42e-05 | 212 | 120 | 8 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.91e-05 | 33 | 120 | 4 | GO:0010880 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.20e-05 | 37 | 120 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 7.66e-05 | 39 | 120 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 9.34e-05 | 41 | 120 | 4 | GO:0086091 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil degranulation | 1.00e-04 | 3 | 120 | 2 | GO:0043314 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 1.03e-04 | 42 | 120 | 4 | GO:0003230 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.09e-04 | 129 | 120 | 6 | GO:0002027 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.24e-04 | 44 | 120 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 1.28e-04 | 256 | 120 | 8 | GO:0032412 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.55e-04 | 87 | 120 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 1.67e-04 | 266 | 120 | 8 | GO:0022898 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 1.72e-04 | 89 | 120 | 5 | GO:0055117 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | CACNA1C CACNA1D HIF1A ABR ANK2 CAMK4 ATP8A2 RAB8B HNRNPM BCR KIF3A AKAP9 LRP1 DMD RIOK2 ATP2B1 DNM2 | 1.73e-04 | 1081 | 120 | 17 | GO:0051050 |
| GeneOntologyBiologicalProcess | pancreas morphogenesis | 2.00e-04 | 4 | 120 | 2 | GO:0061113 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 2.20e-04 | 277 | 120 | 8 | GO:0090276 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 2.25e-04 | 278 | 120 | 8 | GO:0031503 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 2.38e-04 | 52 | 120 | 4 | GO:0003009 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 2.48e-04 | 282 | 120 | 8 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 2.48e-04 | 282 | 120 | 8 | GO:0002791 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.97e-04 | 100 | 120 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 3.12e-04 | 23 | 120 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | acinar cell differentiation | 3.32e-04 | 5 | 120 | 2 | GO:0090425 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 3.32e-04 | 5 | 120 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 3.32e-04 | 5 | 120 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 3.67e-04 | 299 | 120 | 8 | GO:0032409 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 3.85e-04 | 380 | 120 | 9 | GO:1904062 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.39e-04 | 167 | 120 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | heart development | CACNA1C HIF1A MYH11 ANK2 NSD2 WNT2 GRHL2 KIF3A ALPK3 LRP1 COL14A1 DNM2 PROX1 | 4.67e-04 | 757 | 120 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 4.81e-04 | 111 | 120 | 5 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transporter activity | 4.98e-04 | 63 | 120 | 4 | GO:1901016 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 5.40e-04 | 317 | 120 | 8 | GO:0090257 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 5.65e-04 | 115 | 120 | 5 | GO:0150115 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 6.42e-04 | 249 | 120 | 7 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 6.48e-04 | 326 | 120 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel remodeling | 6.92e-04 | 7 | 120 | 2 | GO:0060313 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane repolarization | 6.95e-04 | 30 | 120 | 3 | GO:0099623 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 6.95e-04 | 30 | 120 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 7.04e-04 | 69 | 120 | 4 | GO:0050881 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 7.50e-04 | 417 | 120 | 9 | GO:0034765 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 7.59e-04 | 334 | 120 | 8 | GO:0030072 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 7.66e-04 | 31 | 120 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | muscle cell development | 8.09e-04 | 259 | 120 | 7 | GO:0055001 | |
| GeneOntologyBiologicalProcess | developmental growth | CACNA1C ATRX WNT2 ATP8A2 GRHL2 KMT2C LRP1 LRP4 MACF1 COL14A1 DMD VCL DNM2 PROX1 | 8.42e-04 | 911 | 120 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 8.42e-04 | 32 | 120 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C CACNA1D MYH8 MYH11 ABR ANK2 BCR AKAP9 INF2 LRP1 ARHGAP28 TNNT1 DNM2 PROX1 | 8.51e-04 | 912 | 120 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 8.70e-04 | 73 | 120 | 4 | GO:0050879 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.86e-04 | 127 | 120 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | peptide secretion | 9.01e-04 | 343 | 120 | 8 | GO:0002790 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 9.19e-04 | 8 | 120 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue morphogenesis | 9.19e-04 | 8 | 120 | 2 | GO:0055009 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.01e-03 | 34 | 120 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.01e-03 | 269 | 120 | 7 | GO:0002064 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.09e-03 | 133 | 120 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 1.10e-03 | 35 | 120 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 1.12e-03 | 355 | 120 | 8 | GO:0046883 | |
| GeneOntologyBiologicalProcess | peptide transport | 1.12e-03 | 355 | 120 | 8 | GO:0015833 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.13e-03 | 134 | 120 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | action potential | 1.16e-03 | 201 | 120 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C CACNA1D HIF1A ABR ANK2 IRAG1 BCR AKAP9 LRP1 DMD FKBP1B ATP2B1 | 1.17e-03 | 733 | 120 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of neutrophil degranulation | 1.18e-03 | 9 | 120 | 2 | GO:0043313 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of mitotic sister chromatid cohesion | 1.18e-03 | 9 | 120 | 2 | GO:0034182 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.18e-03 | 9 | 120 | 2 | GO:0160063 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.19e-03 | 36 | 120 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.21e-03 | 359 | 120 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | viral genome replication | 1.24e-03 | 137 | 120 | 5 | GO:0019079 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 1.28e-03 | 138 | 120 | 5 | GO:2001257 | |
| GeneOntologyCellularComponent | postsynapse | CACNA1C FILIP1 ABR ANK2 KALRN CAMK4 HNRNPM RPS15A PHB2 NBEA BCR KIF3A RAB8A AKAP9 CAMKV PIK3C3 LRP1 LRP4 MACF1 DMD ATP2B1 DNM2 | 8.25e-08 | 1018 | 121 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | CACNA1C ABR ANK2 KALRN HNRNPM PHB2 BCR RAB8A AKAP9 LRP1 LRP4 MACF1 DMD DNM2 | 3.58e-07 | 451 | 121 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | CACNA1C ABR ANK2 KALRN HNRNPM PHB2 BCR RAB8A AKAP9 LRP1 LRP4 MACF1 DMD DNM2 | 7.00e-07 | 477 | 121 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | CACNA1C ABR ANK2 KALRN HNRNPM PHB2 BCR RAB8A AKAP9 LRP1 LRP4 MACF1 DMD DNM2 | 1.31e-06 | 503 | 121 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | CACNA1C ABR ANK2 KALRN HNRNPM PHB2 BCR RAB8A AKAP9 LRP1 LRP4 MACF1 DMD DNM2 | 2.07e-06 | 523 | 121 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1C FILIP1 ABR KALRN CAMK4 HNRNPM PHB2 NBEA BCR KIF3A RAB8A AKAP9 CAMKV PIK3C3 LRP1 ATP2B1 DNM2 | 4.81e-06 | 817 | 121 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.89e-05 | 290 | 121 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 1.02e-04 | 249 | 121 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.92e-04 | 273 | 121 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | Z disc | 2.50e-04 | 151 | 121 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | costamere | 2.69e-04 | 22 | 121 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | I band | 4.15e-04 | 166 | 121 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1C CACNA1D CACNA1F ABR KALRN GPR37 BCR KIF3A RAB8A KHSRP ZWINT AKAP9 LRP1 LRP4 KCNAB1 DMD ATP2B1 | 7.10e-04 | 1228 | 121 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | ribbon synapse | 8.30e-04 | 32 | 121 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | calcium channel complex | 8.54e-04 | 73 | 121 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cell body | CACNA1C CACNA1D CACNA1F KALRN KIF3A RAB8A KHSRP PTPN13 AKAP9 LRP1 LRP4 KCNAB1 DMD ATP2B1 | 9.70e-04 | 929 | 121 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1C CACNA1D CACNA1F KALRN KIF3A RAB8A KHSRP AKAP9 LRP1 LRP4 KCNAB1 DMD ATP2B1 | 1.11e-03 | 835 | 121 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.16e-03 | 9 | 121 | 2 | GO:0160064 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.38e-03 | 83 | 121 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | dendrite | CACNA1C CACNA1D ABR GPR37 BCR RAB8A KHSRP ZWINT AKAP9 LRP1 LRP4 KCNAB1 ATP2B1 | 1.41e-03 | 858 | 121 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1C CACNA1D ABR GPR37 BCR RAB8A KHSRP ZWINT AKAP9 LRP1 LRP4 KCNAB1 ATP2B1 | 1.44e-03 | 860 | 121 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.92e-03 | 576 | 121 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.09e-03 | 583 | 121 | 10 | GO:0097060 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.11e-03 | 12 | 121 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.40e-03 | 46 | 121 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | 2.49e-03 | 235 | 121 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | endoplasmic reticulum chaperone complex | 2.49e-03 | 13 | 121 | 2 | GO:0034663 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.68e-03 | 164 | 121 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.87e-03 | 49 | 121 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.89e-03 | 14 | 121 | 2 | GO:0072379 | |
| GeneOntologyCellularComponent | centriole | 3.28e-03 | 172 | 121 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1C CACNA1D KRT1 MYH8 MYH11 ANK2 KIF3A AFAP1 INF2 MACF1 DMD TNNT1 FKBP1B VCL DNM2 | 3.35e-03 | 1179 | 121 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1C CACNA1D KRT1 MYH8 MYH11 ANK2 KIF3A AFAP1 INF2 MACF1 DMD TNNT1 FKBP1B VCL DNM2 | 3.57e-03 | 1187 | 121 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | muscle myosin complex | 3.78e-03 | 16 | 121 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.19e-03 | 56 | 121 | 3 | GO:0099091 | |
| Domain | CAC1F_C | 2.33e-07 | 3 | 116 | 3 | IPR031688 | |
| Domain | CAC1F_C | 2.33e-07 | 3 | 116 | 3 | PF16885 | |
| Domain | VDCC_L_a1su | 9.30e-07 | 4 | 116 | 3 | IPR005446 | |
| Domain | Ca_chan_IQ | 8.02e-06 | 7 | 116 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 8.02e-06 | 7 | 116 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 8.02e-06 | 7 | 116 | 3 | IPR014873 | |
| Domain | GPHH | 8.02e-06 | 7 | 116 | 3 | PF16905 | |
| Domain | GPHH_dom | 8.02e-06 | 7 | 116 | 3 | IPR031649 | |
| Domain | VDCCAlpha1 | 2.71e-05 | 10 | 116 | 3 | IPR002077 | |
| Domain | Spectrin | 3.78e-04 | 23 | 116 | 3 | PF00435 | |
| Domain | Kinase-like_dom | KALRN CAMK4 LRRK1 PTPN13 CAMKV PIK3C3 ALPK3 MACF1 DMD RIOK2 DNM2 | 5.59e-04 | 542 | 116 | 11 | IPR011009 |
| Domain | DH_1 | 6.34e-04 | 63 | 116 | 4 | PS00741 | |
| Domain | Spectrin_repeat | 7.58e-04 | 29 | 116 | 3 | IPR002017 | |
| Domain | RhoGEF | 8.47e-04 | 68 | 116 | 4 | SM00325 | |
| Domain | RhoGEF | 9.45e-04 | 70 | 116 | 4 | PF00621 | |
| Domain | DH_2 | 9.45e-04 | 70 | 116 | 4 | PS50010 | |
| Domain | - | 9.96e-04 | 71 | 116 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 9.96e-04 | 71 | 116 | 4 | IPR000219 | |
| Domain | SPEC | 1.02e-03 | 32 | 116 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.02e-03 | 32 | 116 | 3 | IPR018159 | |
| Domain | GDS_CDC24_CS | 1.81e-03 | 39 | 116 | 3 | IPR001331 | |
| Domain | P-loop_NTPase | MYH8 MYH11 ATRX RAB8B LRRK1 KIF3A RAB8A ABCA6 SLFN13 MTIF2 DDX18 RECQL5 DNM2 | 2.33e-03 | 848 | 116 | 13 | IPR027417 |
| Domain | PH | 3.08e-03 | 229 | 116 | 6 | PF00169 | |
| Domain | Ldl_recept_b | 3.31e-03 | 14 | 116 | 2 | PF00058 | |
| Domain | LDLRB | 3.31e-03 | 14 | 116 | 2 | PS51120 | |
| Domain | LY | 3.81e-03 | 15 | 116 | 2 | SM00135 | |
| Domain | Myosin_N | 3.81e-03 | 15 | 116 | 2 | PF02736 | |
| Domain | Myosin_N | 3.81e-03 | 15 | 116 | 2 | IPR004009 | |
| Domain | LDLR_classB_rpt | 3.81e-03 | 15 | 116 | 2 | IPR000033 | |
| Domain | Post-SET_dom | 4.34e-03 | 16 | 116 | 2 | IPR003616 | |
| Domain | PostSET | 4.34e-03 | 16 | 116 | 2 | SM00508 | |
| Domain | POST_SET | 4.34e-03 | 16 | 116 | 2 | PS50868 | |
| Domain | PH_dom-like | 5.12e-03 | 426 | 116 | 8 | IPR011993 | |
| Domain | Channel_four-helix_dom | 5.35e-03 | 57 | 116 | 3 | IPR027359 | |
| Domain | - | 5.35e-03 | 57 | 116 | 3 | 1.20.120.350 | |
| Domain | Myosin_tail_1 | 5.48e-03 | 18 | 116 | 2 | PF01576 | |
| Domain | Myosin_tail | 5.48e-03 | 18 | 116 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.10e-03 | 19 | 116 | 2 | IPR027401 | |
| Domain | - | 6.10e-03 | 19 | 116 | 2 | 4.10.270.10 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.51e-06 | 165 | 94 | 9 | MM15026 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 5.66e-06 | 6 | 94 | 3 | M47762 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.24e-06 | 203 | 94 | 9 | M5485 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 9.91e-05 | 14 | 94 | 3 | M47692 | |
| Pubmed | DCAF1 DCAF8 HYOU1 IPO8 ANK2 ATRX IFT81 HNRNPM CCDC18 PHB2 PYM1 PSMD7 DNAJB14 LRRC47 PTPN13 AKAP9 DNAJC10 INF2 CCDC47 MTIF2 GLYR1 DDX18 EIF2B4 MACF1 COL14A1 EMC2 ATP2B1 TOP2B VCL | 2.51e-14 | 1487 | 121 | 29 | 33957083 | |
| Pubmed | CACNA1C KRT1 MYH8 MYH11 HYOU1 ANK2 ATRX NSD2 RAB8B IFT81 HNRNPM PHB2 PSMD7 DNAJB14 RAB8A KHSRP DNAJC10 CCDC47 MACF1 ALDH1B1 DMD EMC2 TNNT1 TMCO1 ATP2B1 TOP2B | 4.02e-12 | 1442 | 121 | 26 | 35575683 | |
| Pubmed | KRT1 MYH11 SERBP1 HYOU1 ANK2 KALRN MARS1 HNRNPM RPS15A PHB2 NBEA BCR ARCN1 KIF3A KHSRP LRRC47 AFAP1 CAMKV INF2 MACF1 ALDH1B1 DMD ATP2B1 VCL DNM2 | 2.19e-11 | 1431 | 121 | 25 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 MIS18BP1 MARS1 HNRNPM RPS15A PHB2 PSMD7 ARCN1 KHSRP LRRC47 PSME4 INF2 CCDC47 GLYR1 DDX18 RECQL5 EIF2B4 MACF1 ALDH1B1 RIOK2 ATP2B1 TOP2B VCL | 2.67e-10 | 1353 | 121 | 23 | 29467282 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 CACNA1C HIF1A DCAF8 ABR ATRX NSD2 MARS1 CPT1A BCR GRHL2 KMT2C USF3 PTPN13 FAM111A INF2 PIK3C3 GLYR1 EIF2B4 LRP1 MACF1 ANKRD12 ATP2B1 SOS2 | 3.00e-10 | 1489 | 121 | 24 | 28611215 |
| Pubmed | SERBP1 REPS1 ABR HYOU1 ANK2 MARS1 HNRNPM RPS15A PHB2 ARCN1 ARFGAP2 TBC1D10B PTPN13 CCDC47 MACF1 ATP2B1 VCL | 4.53e-10 | 708 | 121 | 17 | 39231216 | |
| Pubmed | TET2 KRT1 SERBP1 HYOU1 HNRNPM PHB2 ARCN1 RAB8A KHSRP LRRC47 KMT2C CCDC47 DDX18 EIF2B4 MACF1 ALDH1B1 DNM2 | 4.83e-10 | 711 | 121 | 17 | 33022573 | |
| Pubmed | TET2 REPS1 DCAF8 ANK2 ATRX KALRN IFT81 NBEA PSMD7 REV3L ARCN1 KIF3A PTPN13 SLF2 MTIF2 DDX18 LRP1 LRP4 MACF1 DNM2 SOS2 | 3.55e-09 | 1285 | 121 | 21 | 35914814 | |
| Pubmed | KRT1 SERBP1 REPS1 DCAF8 HYOU1 IPO8 MARS1 PHB2 PSMD7 ARCN1 KHSRP LRRC47 AFAP1 DNAJC10 INF2 CCDC47 EIF2B4 LRP4 ALDH1B1 EMC2 ATP2B1 TOP2B | 4.88e-09 | 1440 | 121 | 22 | 30833792 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH8 MYH11 HYOU1 IPO8 MARS1 HNRNPM PSMD7 DNAJB14 ARCN1 KHSRP EIF2B4 ALDH1B1 ATP2B1 VCL DNM2 | 8.26e-09 | 647 | 121 | 15 | 26618866 |
| Pubmed | SERBP1 ANK2 KALRN CAMK4 HNRNPM PHB2 NBEA PSMD7 BCR ARCN1 KHSRP ZWINT ARFGAP2 CAMKV GLYR1 KCNAB1 MACF1 ALDH1B1 EMC2 | 1.56e-08 | 1139 | 121 | 19 | 36417873 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 SERBP1 HYOU1 MARS1 HNRNPM RPS15A PHB2 PYM1 CPT1A ARCN1 KHSRP LRRC47 GTF2E1 DNAJC10 CCDC47 DDX18 EIF2B4 MACF1 EMC2 RIOK2 TOP2B | 1.89e-08 | 1415 | 121 | 21 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SERBP1 HYOU1 IPO8 ATRX NSD2 MARS1 HNRNPM RPS15A PHB2 PSMD7 ARCN1 KHSRP LRRC47 CCDC47 GLYR1 DDX18 ALDH1B1 EMC2 ATP2B1 TOP2B VCL | 2.13e-08 | 1425 | 121 | 21 | 30948266 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SERBP1 REPS1 ANK2 ATRX MARS1 CAMK4 HNRNPM PYM1 PSMD7 ARCN1 KHSRP GTF2E1 PTPN13 MACF1 TOP2B VCL DNM2 | 2.75e-08 | 934 | 121 | 17 | 33916271 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | KRT1 ESS2 HYOU1 MARS1 HNRNPM RPS15A PHB2 UTP23 PSMD7 ARCN1 RAB8A KHSRP FAM111A CCDC47 DDX18 EIF2B4 RIOK2 LRIF1 TOP2B DNM2 | 2.99e-08 | 1318 | 121 | 20 | 30463901 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SERBP1 ABR HYOU1 RBM33 RPS15A PYM1 BCR KHSRP PTPN13 DDX18 MACF1 ZMYM1 TMCO1 TOP2B VCL | 3.64e-08 | 724 | 121 | 15 | 36232890 |
| Pubmed | KRT1 MYH11 SERBP1 REPS1 ANK2 PHB2 PYM1 ARCN1 RAB8A KHSRP LRRC47 TBC1D10B FAM111A AKAP9 CCDC47 GLYR1 DDX18 EIF2B4 COL14A1 RIOK2 | 5.69e-08 | 1371 | 121 | 20 | 36244648 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | KRT1 SERBP1 HNRNPM RPS15A PYM1 INF2 CCDC47 EIF2B4 EMC2 TMCO1 ATP2B1 | 8.77e-08 | 375 | 121 | 11 | 32788342 |
| Pubmed | 9.10e-08 | 222 | 121 | 9 | 37071664 | ||
| Pubmed | KRT1 MYH11 SERBP1 MARS1 RAB8B HNRNPM RPS15A PHB2 PSMD7 ARCN1 RAB8A KHSRP USF3 DNAJC10 GLYR1 DDX18 MACF1 ALDH1B1 | 1.04e-07 | 1153 | 121 | 18 | 29845934 | |
| Pubmed | KRT1 SERBP1 ABR HYOU1 MARS1 HNRNPM RPS15A PSMD7 CPT1A BCR DNAJB14 ARCN1 KHSRP DNAJC10 PIK3C3 CCDC47 DDX18 ATP2B1 | 1.26e-07 | 1168 | 121 | 18 | 19946888 | |
| Pubmed | REPS1 ESS2 ABR IPO8 RBM33 RAB8B NBEA PSMD7 BCR ARCN1 RAB8A CCDC47 ARHGAP28 DMD DNM2 SOS2 | 1.28e-07 | 916 | 121 | 16 | 32203420 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 KRT1 MIS18BP1 ESS2 ATRX RBM33 ZCCHC2 BCR ZWINT SLF2 RECQL5 MACF1 LRIF1 | 1.50e-07 | 588 | 121 | 13 | 38580884 |
| Pubmed | SERBP1 RBM33 MARS1 HNRNPM RPS15A PHB2 PYM1 ARCN1 KIF3A KHSRP TBC1D10B DNAJC10 DDX18 EIF2B4 DMD | 1.53e-07 | 809 | 121 | 15 | 32129710 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 20937870 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DCAF1 HIF1A MIS18BP1 IPO8 RBM33 MARS1 RAB8B HNRNPM PHB2 RAB8A TBC1D10B FAM111A DNAJC10 LRP1 ZMYM1 TMCO1 ATP2B1 TOP2B | 1.95e-07 | 1203 | 121 | 18 | 29180619 |
| Pubmed | HYOU1 MARS1 HNRNPM PSMD7 CPT1A VWDE LRRC47 DDX18 LRP1 ALDH1B1 EMC2 TMCO1 DNM2 | 2.41e-07 | 613 | 121 | 13 | 22268729 | |
| Pubmed | ABR ANK2 KALRN HNRNPM PHB2 NBEA BCR KIF3A KHSRP AKAP9 CAMKV LRP1 KCNAB1 MACF1 DNM2 PROX1 | 2.50e-07 | 963 | 121 | 16 | 28671696 | |
| Pubmed | KRT1 SERBP1 HYOU1 MARS1 HNRNPM RPS15A PHB2 KHSRP DNAJC10 CCDC47 DDX18 ALDH1B1 ATP2B1 DNM2 | 2.51e-07 | 725 | 121 | 14 | 27025967 | |
| Pubmed | DCAF1 KRT1 HIF1A PHB2 FUNDC1 CPT1A KHSRP ZWINT PIK3C3 CCDC47 DNM2 | 4.02e-07 | 437 | 121 | 11 | 20562859 | |
| Pubmed | 4.19e-07 | 266 | 121 | 9 | 19380743 | ||
| Pubmed | MIS18BP1 ESS2 NSD2 IFT81 CCDC18 PHB2 PSMD7 ZNF226 KIF3A LRRC47 GLYR1 RECQL5 LRIF1 | 4.28e-07 | 645 | 121 | 13 | 25281560 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SERBP1 IPO8 NSD2 HNRNPM RPS15A AGGF1 ARCN1 DNAJC10 PIK3C3 GLYR1 DDX18 EIF2B4 MACF1 TOP2B | 4.34e-07 | 759 | 121 | 14 | 35915203 |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 8.77e-07 | 50 | 121 | 5 | 27597886 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 SERBP1 HYOU1 MARS1 HNRNPM RPS15A PHB2 CPT1A ARCN1 AKAP9 DDX18 MACF1 VCL DNM2 | 8.97e-07 | 807 | 121 | 14 | 30575818 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 HYOU1 MARS1 HNRNPM PHB2 CPT1A DNAJB14 ARCN1 LRRC47 TBC1D10B INF2 CCDC47 EIF2B4 EMC2 TMCO1 | 1.04e-06 | 942 | 121 | 15 | 31073040 |
| Pubmed | 1.06e-06 | 151 | 121 | 7 | 17043677 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | KRT1 MYH11 SERBP1 MARS1 RAB8B HNRNPM RPS15A PHB2 UTP23 RAB8A LRRC47 TBC1D10B GLYR1 DDX18 RIOK2 | 1.14e-06 | 949 | 121 | 15 | 36574265 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT1 KALRN NSD2 HNRNPM RPS15A PHB2 KHSRP TBC1D10B PTPN13 AFAP1 DNAJC10 GLYR1 DDX18 MACF1 TOP2B PROX1 | 1.16e-06 | 1082 | 121 | 16 | 38697112 |
| Pubmed | MYH8 REPS1 ANK2 KALRN KIF3A AKAP9 MACF1 COL14A1 TNNT1 VCL DNM2 | 1.41e-06 | 497 | 121 | 11 | 23414517 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 12900400 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | SERBP1 MARS1 HNRNPM RPS15A PHB2 PSMD7 CPT1A ARCN1 KHSRP ZWINT LRRC47 PSME4 DNAJC10 CCDC47 ALDH1B1 TMCO1 DNM2 | 1.76e-06 | 1257 | 121 | 17 | 37317656 |
| Pubmed | SERBP1 HYOU1 IPO8 MARS1 HNRNPM PHB2 PSMD7 ARCN1 INF2 CCDC47 DDX18 ALDH1B1 TMCO1 ATP2B1 | 2.40e-06 | 878 | 121 | 14 | 37223481 | |
| Pubmed | HYOU1 IPO8 RBM33 MARS1 HNRNPM PSMD7 ARCN1 LRRC47 DNAJC10 DDX18 TOP2B DNM2 | 2.49e-06 | 638 | 121 | 12 | 33239621 | |
| Pubmed | 2.93e-06 | 251 | 121 | 8 | 27507650 | ||
| Pubmed | KRT1 SERBP1 ATRX HNRNPM RPS15A PHB2 RAB8A KHSRP DDX18 RECQL5 LRIF1 TOP2B | 3.11e-06 | 652 | 121 | 12 | 31180492 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 3.39e-06 | 256 | 121 | 8 | 32698014 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIS18BP1 ESS2 HYOU1 IPO8 RBM33 RPS15A PHB2 PYM1 PSMD7 RAB8A AKAP9 INF2 CCDC47 MTIF2 DDX18 ALDH1B1 EMC2 TMCO1 | 4.36e-06 | 1496 | 121 | 18 | 32877691 |
| Pubmed | DCAF1 DCAF8 HYOU1 MARS1 PHB2 PSMD7 LRRC47 AKAP9 CCDC47 ATP2B1 | 4.80e-06 | 457 | 121 | 10 | 22190034 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 4.82e-06 | 358 | 121 | 9 | 32460013 | |
| Pubmed | SERBP1 IPO8 MARS1 HNRNPM RPS15A PHB2 KHSRP DDX18 ZMYM1 ATP2B1 | 5.38e-06 | 463 | 121 | 10 | 34901782 | |
| Pubmed | ESS2 DCAF8 IPO8 RPS15A AGGF1 PSMD7 KMT2C FAM111A AKAP9 INF2 CCDC47 LRIF1 | 5.44e-06 | 689 | 121 | 12 | 36543142 | |
| Pubmed | HYOU1 ATRX MARS1 PYM1 ZCCHC2 KMT2C PTPN13 PSME4 INF2 GLYR1 MACF1 ANKRD12 ZMYM1 ATP2B1 DNM2 | 5.73e-06 | 1084 | 121 | 15 | 11544199 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 18809727 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DCAF8 ATRX KALRN KIF3A KHSRP LRRC47 TBC1D10B DNAJC10 MTIF2 TOP2B | 6.73e-06 | 475 | 121 | 10 | 31040226 |
| Pubmed | HIF1A SERBP1 REPS1 MARS1 HNRNPM RPS15A ARCN1 KIF3A LRRC47 ELL2 AKAP9 INF2 DDX18 ALDH1B1 VCL DNM2 | 7.06e-06 | 1247 | 121 | 16 | 27684187 | |
| Pubmed | SERBP1 IPO8 ANK2 MARS1 HNRNPM RPS15A PYM1 PSMD7 ARCN1 KHSRP LRRC47 LRP1 TMCO1 ATP2B1 | 7.57e-06 | 971 | 121 | 14 | 33306668 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 DCAF8 HYOU1 IPO8 PSMD7 CPT1A BCR KHSRP DNAJC10 EIF2B4 LRP1 DMD ATP2B1 VCL | 7.84e-06 | 974 | 121 | 14 | 28675297 |
| Pubmed | DCAF1 DCAF8 NSD2 HNRNPM SCEL REV3L BCR TBC1D10B DNAJC10 MTIF2 DDX18 LRP1 LRP4 MACF1 PROX1 | 8.10e-06 | 1116 | 121 | 15 | 31753913 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | KRT1 SERBP1 HNRNPM RPS15A PHB2 PSMD7 KHSRP TBC1D10B PTPN13 DDX18 TOP2B | 9.02e-06 | 604 | 121 | 11 | 37616343 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.39e-06 | 38 | 121 | 4 | 30786075 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 CACNA1C RBM33 GPR37 MARS1 IFT81 NBEA PSMD7 KMT2C DNAJC10 | 9.97e-06 | 497 | 121 | 10 | 36774506 |
| Pubmed | 1.03e-05 | 298 | 121 | 8 | 30737378 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | KRT1 SERBP1 DCAF8 HYOU1 MARS1 HNRNPM RPS15A PYM1 PSMD7 ARCN1 KHSRP EIF2B4 MACF1 VCL DNM2 | 1.14e-05 | 1149 | 121 | 15 | 35446349 |
| Pubmed | 1.19e-05 | 304 | 121 | 8 | 32235678 | ||
| Pubmed | Vestibular dysgenesis in mice lacking Abr and Bcr Cdc42/RacGAPs. | 1.20e-05 | 2 | 121 | 2 | 11921339 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15143342 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21054386 | ||
| Pubmed | Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. | 1.20e-05 | 2 | 121 | 2 | 7479768 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23436330 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 1.20e-05 | 2 | 121 | 2 | 25966695 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26880370 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26310281 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24086669 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21454812 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17982130 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 1.20e-05 | 2 | 121 | 2 | 26049024 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 1.20e-05 | 2 | 121 | 2 | 16706838 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23761887 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 1.20e-05 | 2 | 121 | 2 | 25292336 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17526649 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 1.20e-05 | 2 | 121 | 2 | 24941892 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 1.20e-05 | 2 | 121 | 2 | 16921373 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24470632 | ||
| Pubmed | SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex. | 1.20e-05 | 2 | 121 | 2 | 26398198 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24760982 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20014384 | ||
| Pubmed | Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. | 1.20e-05 | 2 | 121 | 2 | 21859974 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30001160 | ||
| Pubmed | FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia. | 1.20e-05 | 2 | 121 | 2 | 35864106 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38584135 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21352396 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 1.20e-05 | 2 | 121 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 1.20e-05 | 2 | 121 | 2 | 16267232 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24996399 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24849370 | ||
| Interaction | KCTD13 interactions | KRT1 MYH11 SERBP1 HYOU1 ANK2 KALRN MARS1 HNRNPM RPS15A PHB2 NBEA BCR ARCN1 KIF3A KHSRP LRRC47 AFAP1 CAMKV INF2 MACF1 ALDH1B1 DMD ATP2B1 VCL DNM2 | 4.77e-07 | 1394 | 119 | 25 | int:KCTD13 |
| Interaction | UNC93B1 interactions | KRT1 DCAF8 IPO8 MARS1 PHB2 ARCN1 KHSRP DNAJC10 CCDC47 EIF2B4 EMC2 TMCO1 ATP2B1 | 1.13e-06 | 417 | 119 | 13 | int:UNC93B1 |
| Interaction | LRRC59 interactions | KRT1 MYH8 MYH11 SERBP1 HYOU1 HNRNPM RPS15A PHB2 PYM1 DNAJC10 INF2 CCDC47 EIF2B4 ETAA1 COL14A1 EMC2 ATP2B1 VCL | 2.30e-06 | 845 | 119 | 18 | int:LRRC59 |
| Interaction | KCNA3 interactions | SERBP1 REPS1 ABR HYOU1 ANK2 MARS1 HNRNPM RPS15A PHB2 ARCN1 KMT2C ARFGAP2 TBC1D10B PTPN13 CCDC47 MACF1 ATP2B1 VCL | 3.51e-06 | 871 | 119 | 18 | int:KCNA3 |
| Interaction | PRC1 interactions | BDP1 SERBP1 ATRX MARS1 ATP8A2 HNRNPM RPS15A PHB2 PSMD7 KHSRP USF3 AFAP1 AKAP9 INF2 GLYR1 DDX18 CCDC68 TOP2B VCL | 4.15e-06 | 973 | 119 | 19 | int:PRC1 |
| Interaction | FGFR1 interactions | REPS1 ABR HYOU1 ANK2 NBEA ARCN1 RAB8A ARFGAP2 TBC1D10B PTPN13 AFAP1 SHE ATP2B1 VCL DNM2 | 4.80e-06 | 632 | 119 | 15 | int:FGFR1 |
| Interaction | CFTR interactions | KRT1 MYH8 MYH11 REPS1 HYOU1 IPO8 MARS1 HNRNPM PHB2 PSMD7 BCR DNAJB14 ARCN1 KIF3A KHSRP CAMKV EIF2B4 MACF1 ALDH1B1 DMD EMC2 ATP2B1 VCL DNM2 | 4.91e-06 | 1480 | 119 | 24 | int:CFTR |
| Interaction | SLX4 interactions | SERBP1 MIS18BP1 ESS2 IPO8 ATRX RBM33 HNRNPM PHB2 REV3L KHSRP SLF2 DDX18 RECQL5 LRIF1 | 7.20e-06 | 572 | 119 | 14 | int:SLX4 |
| Interaction | SLC15A3 interactions | 1.05e-05 | 234 | 119 | 9 | int:SLC15A3 | |
| Interaction | P2RY6 interactions | DCAF8 IPO8 MARS1 PHB2 PSMD7 ARCN1 DNAJC10 CCDC47 EIF2B4 EMC2 ATP2B1 | 1.79e-05 | 385 | 119 | 11 | int:P2RY6 |
| Interaction | RHOB interactions | ABR RAB8B UTP23 NBEA BCR RAB8A TBC1D10B PTPN13 DDX18 LRP4 MACF1 ALDH1B1 EMC2 TMCO1 ATP2B1 TOP2B | 3.49e-05 | 840 | 119 | 16 | int:RHOB |
| Interaction | EFTUD2 interactions | KRT1 HIF1A SERBP1 ESS2 MARS1 HNRNPM RPS15A PHB2 PYM1 CPT1A ARCN1 KHSRP LRRC47 GTF2E1 DNAJC10 CCDC47 DDX18 EIF2B4 MACF1 EMC2 RIOK2 TOP2B | 3.60e-05 | 1449 | 119 | 22 | int:EFTUD2 |
| Interaction | CAPZB interactions | DCAF1 MYH11 SERBP1 REPS1 IPO8 MARS1 HNRNPM RPS15A RAB8A KHSRP DNAJC10 INF2 PIK3C3 TMCO1 RIOK2 TOP2B VCL DNM2 | 4.30e-05 | 1049 | 119 | 18 | int:CAPZB |
| Interaction | HDAC2 interactions | DCAF1 TET2 KRT1 HIF1A SERBP1 ESS2 NSD2 MARS1 PHB2 KHSRP INF2 EIF2B4 COL14A1 DMD TOP2B VCL | 4.95e-05 | 865 | 119 | 16 | int:HDAC2 |
| Interaction | NAA40 interactions | SERBP1 REPS1 ANK2 ATRX MARS1 CAMK4 HNRNPM PYM1 PSMD7 ARCN1 KHSRP GTF2E1 PTPN13 MACF1 TOP2B VCL DNM2 | 6.12e-05 | 978 | 119 | 17 | int:NAA40 |
| Interaction | HECTD1 interactions | HIF1A SERBP1 IPO8 NSD2 HNRNPM RPS15A PHB2 AGGF1 ARCN1 DNAJC10 PIK3C3 GLYR1 DDX18 EIF2B4 MACF1 RIOK2 TOP2B | 6.60e-05 | 984 | 119 | 17 | int:HECTD1 |
| Interaction | NR2C2 interactions | DCAF1 KRT1 ESS2 HYOU1 MARS1 HNRNPM RPS15A PHB2 UTP23 PSMD7 ARCN1 RAB8A KHSRP FAM111A CCDC47 DDX18 EIF2B4 RIOK2 LRIF1 TOP2B DNM2 | 6.83e-05 | 1403 | 119 | 21 | int:NR2C2 |
| Interaction | DSCAM interactions | 7.06e-05 | 171 | 119 | 7 | int:DSCAM | |
| Interaction | WDR5 interactions | TET2 KRT1 SERBP1 HYOU1 HNRNPM PHB2 ARCN1 RAB8A KHSRP LRRC47 KMT2C CCDC47 DDX18 EIF2B4 MACF1 ALDH1B1 LRIF1 DNM2 | 8.01e-05 | 1101 | 119 | 18 | int:WDR5 |
| Interaction | RORA interactions | 8.10e-05 | 39 | 119 | 4 | int:RORA | |
| Interaction | ACE2 interactions | TET2 CACNA1C KRT1 SERBP1 HYOU1 IPO8 MARS1 HNRNPM RPS15A PHB2 NBEA PSMD7 ARCN1 KHSRP LRRC47 TBC1D10B DDX18 TOP2B | 8.49e-05 | 1106 | 119 | 18 | int:ACE2 |
| Interaction | FBXO6 interactions | HYOU1 MARS1 HNRNPM PSMD7 CPT1A VWDE LRRC47 DNAJC10 DDX18 LRP1 ALDH1B1 EMC2 TMCO1 DNM2 | 8.60e-05 | 717 | 119 | 14 | int:FBXO6 |
| Interaction | C9orf72 interactions | SERBP1 MARS1 RAB8B HNRNPM RPS15A PHB2 PSMD7 CPT1A ARCN1 RAB8A KHSRP ZWINT LRRC47 PSME4 DNAJC10 CCDC47 ALDH1B1 TMCO1 VCL DNM2 | 8.74e-05 | 1319 | 119 | 20 | int:C9orf72 |
| Interaction | HUWE1 interactions | SERBP1 REPS1 DCAF8 MARS1 RPS15A PHB2 UTP23 PSMD7 ZCCHC2 CPT1A ARCN1 RAB8A KHSRP ZWINT TBC1D10B AKAP9 CCDC47 MACF1 | 8.88e-05 | 1110 | 119 | 18 | int:HUWE1 |
| Interaction | HEXIM1 interactions | KRT1 HIF1A SERBP1 MARS1 RAB8B HNRNPM RPS15A PHB2 PSMD7 ARCN1 RAB8A KHSRP DNAJC10 DDX18 MACF1 ALDH1B1 | 9.34e-05 | 913 | 119 | 16 | int:HEXIM1 |
| Interaction | BIN1 interactions | 1.18e-04 | 129 | 119 | 6 | int:BIN1 | |
| Interaction | HDAC4 interactions | CACNA1C HIF1A DCAF8 ATRX KALRN CAMK4 REV3L KIF3A KHSRP LRRC47 TBC1D10B DNAJC10 MTIF2 TOP2B | 1.27e-04 | 744 | 119 | 14 | int:HDAC4 |
| Interaction | BRCA1 interactions | HIF1A HYOU1 NSD2 MARS1 HNRNPM RPS15A PHB2 PSMD7 LRRK1 KHSRP GTF2E1 AFAP1 FAM111A DNAJC10 SLF2 RECQL5 ETAA1 TOP2B VCL | 1.29e-04 | 1249 | 119 | 19 | int:BRCA1 |
| Interaction | PAGE4 interactions | 1.31e-04 | 253 | 119 | 8 | int:PAGE4 | |
| Interaction | NOP56 interactions | SERBP1 HYOU1 ATRX HNRNPM RPS15A FAM111A GLYR1 DDX18 RECQL5 EIF2B4 EMC2 TOP2B | 1.42e-04 | 570 | 119 | 12 | int:NOP56 |
| Interaction | PRNP interactions | ESS2 DCAF8 IPO8 ANK2 RPS15A AGGF1 PYM1 PSMD7 KHSRP KMT2C FAM111A AKAP9 INF2 CCDC47 MACF1 DMD ATP2B1 LRIF1 | 1.51e-04 | 1158 | 119 | 18 | int:PRNP |
| Interaction | H1-2 interactions | DCAF1 SERBP1 DCAF8 ANK2 ATRX NSD2 UTP23 REV3L ARFGAP2 USF3 GLYR1 ALDH1B1 ATP2B1 | 1.57e-04 | 666 | 119 | 13 | int:H1-2 |
| Interaction | DIRAS3 interactions | 1.66e-04 | 262 | 119 | 8 | int:DIRAS3 | |
| Interaction | SEC61G interactions | 1.69e-04 | 47 | 119 | 4 | int:SEC61G | |
| Interaction | CALD1 interactions | 1.79e-04 | 265 | 119 | 8 | int:CALD1 | |
| Interaction | ATRX interactions | 1.89e-04 | 267 | 119 | 8 | int:ATRX | |
| Interaction | RRM1 interactions | 1.91e-04 | 141 | 119 | 6 | int:RRM1 | |
| Interaction | BRD1 interactions | 2.06e-04 | 344 | 119 | 9 | int:BRD1 | |
| Interaction | PFN1 interactions | SERBP1 ANK2 NBEA BCR ARFGAP2 AKAP9 INF2 MACF1 LRIF1 VCL DNM2 | 2.17e-04 | 509 | 119 | 11 | int:PFN1 |
| Interaction | SFN interactions | TET2 KRT1 HIF1A MYH11 SERBP1 HNRNPM CCDC18 RPS15A BCR PTPN13 AKAP9 MACF1 VCL | 2.28e-04 | 692 | 119 | 13 | int:SFN |
| Interaction | ECT2 interactions | MYH11 SERBP1 ABR HNRNPM RPS15A PHB2 AGGF1 KHSRP AFAP1 DNAJC10 INF2 CCDC47 MACF1 ALDH1B1 TOP2B | 2.31e-04 | 887 | 119 | 15 | int:ECT2 |
| Interaction | RHOA interactions | SERBP1 ABR CPT1A BCR RAB8A PTPN13 DNAJC10 INF2 PIK3C3 CCDC47 DDX18 MACF1 ALDH1B1 EMC2 TMCO1 ATP2B1 TOP2B DNM2 | 2.32e-04 | 1199 | 119 | 18 | int:RHOA |
| Interaction | MYH6 interactions | 2.38e-04 | 94 | 119 | 5 | int:MYH6 | |
| Interaction | YAP1 interactions | KRT1 HIF1A MYH11 SERBP1 REPS1 ESS2 HYOU1 MARS1 HNRNPM RPS15A PHB2 KHSRP KMT2C PTPN13 DNAJC10 RECQL5 VCL | 2.38e-04 | 1095 | 119 | 17 | int:YAP1 |
| Interaction | VRK1 interactions | 2.42e-04 | 277 | 119 | 8 | int:VRK1 | |
| Interaction | GRB2 interactions | DCAF1 KRT1 MYH11 SERBP1 REPS1 HYOU1 RBM33 PHB2 LRRK1 BCR ADAM12 KIF3A DNM2 SOS2 | 2.89e-04 | 806 | 119 | 14 | int:GRB2 |
| Interaction | BIRC3 interactions | SERBP1 HYOU1 IPO8 MARS1 HNRNPM RPS15A PHB2 PSMD7 ARCN1 KHSRP LRRC47 CCDC47 GLYR1 DDX18 ALDH1B1 EMC2 ATP2B1 TOP2B VCL | 2.99e-04 | 1334 | 119 | 19 | int:BIRC3 |
| Interaction | DNAJC2 interactions | 3.08e-04 | 217 | 119 | 7 | int:DNAJC2 | |
| Interaction | FBXO22 interactions | BDP1 CACNA1C SERBP1 RBM33 GPR37 MARS1 IFT81 NBEA PSMD7 KMT2C DNAJC10 | 3.59e-04 | 540 | 119 | 11 | int:FBXO22 |
| GeneFamily | Calcium voltage-gated channel subunits | 2.25e-04 | 26 | 83 | 3 | 253 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.40e-04 | 66 | 83 | 4 | 722 | |
| GeneFamily | Low density lipoprotein receptors | 1.57e-03 | 13 | 83 | 2 | 634 | |
| GeneFamily | Myosin heavy chains | 2.10e-03 | 15 | 83 | 2 | 1098 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.59e-03 | 206 | 83 | 5 | 682 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 3.04e-03 | 18 | 83 | 2 | 498 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 MIS18BP1 G0S2 AGGF1 REV3L ZCCHC2 DNAJB14 KIF3A PTPN13 FAM111A CCDC47 ETAA1 ZMYM1 EMC2 RIOK2 TOP2B | 6.20e-08 | 656 | 121 | 16 | M18979 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HIF1A MS4A6E CAMK4 ATP8A2 RAB8B AGGF1 PYM1 USF3 NR5A2 MACF1 TMCO1 ATP2B1 TOP2B | 6.68e-07 | 507 | 121 | 13 | MM1030 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIF1A ATRX REV3L PTPN13 AFAP1 ELL2 AKAP9 PSME4 PIK3C3 MTIF2 MACF1 DMD EMC2 ATP2B1 VCL SOS2 | 2.12e-06 | 856 | 121 | 16 | M4500 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HIF1A CAMK4 ATP8A2 RAB8B AGGF1 PYM1 USF3 NR5A2 MACF1 TMCO1 ATP2B1 TOP2B | 3.48e-06 | 498 | 121 | 12 | M1741 |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | 3.85e-05 | 198 | 121 | 7 | M325 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN | 4.11e-05 | 200 | 121 | 7 | M9928 | |
| Coexpression | CORONEL_RFX7_DIRECT_TARGETS_UP | 5.09e-05 | 44 | 121 | 4 | M42500 | |
| Coexpression | TBK1.DF_DN | 5.65e-05 | 286 | 121 | 8 | M2864 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | FILIP1 MYH11 ABR GPR37 CAMK4 WNT2 IFT81 HNRNPM IRAG1 ADAM12 ZWINT FAM111A NR5A2 ETAA1 SHE COL14A1 ARHGAP28 TNNT1 TOP2B VCL DNM2 | 7.56e-09 | 837 | 119 | 21 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | FILIP1 MYH8 MYH11 NPY6R WNT2 IRAG1 COL14A1 ALDH1B1 TNNT1 VCL | 1.31e-07 | 192 | 119 | 10 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.59e-07 | 92 | 119 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | ABR GPR37 WNT2 IFT81 HNRNPM ADAM12 ZWINT FAM111A NR5A2 ETAA1 SHE | 2.08e-06 | 323 | 119 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DCAF1 BDP1 CACNA1F MIS18BP1 REPS1 ATRX CAMK4 CCDC18 ZNF226 REV3L GRHL2 LRRC47 AKAP9 SLF2 MTIF2 CCDC68 MACF1 ZMYM1 LRIF1 | 2.48e-06 | 989 | 119 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 4.05e-06 | 164 | 119 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | FILIP1 MYH11 SERBP1 ATRX RAB8B REV3L IRAG1 RAB8A AKAP9 SHE COL14A1 ARHGAP28 TNNT1 ATP2B1 TOP2B VCL | 6.53e-06 | 772 | 119 | 16 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 8.90e-06 | 86 | 119 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 1.02e-05 | 88 | 119 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.02e-05 | 311 | 119 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 REPS1 ATRX CCDC18 ZWINT GTF2E1 AKAP9 SLF2 MTIF2 MACF1 ZMYM1 DMD EMC2 RIOK2 | 1.17e-05 | 629 | 119 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | FILIP1 MYH11 GPR37 WNT2 IRAG1 ADAM12 SHE COL14A1 TNNT1 TOP2B DNM2 | 2.47e-05 | 420 | 119 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | FILIP1 MYH8 MYH11 WNT2 CPT1A IRAG1 ADAM12 FER1L4 CCDC68 KCNAB1 SHE COL14A1 TNNT1 TOP2B DNM2 | 2.84e-05 | 774 | 119 | 15 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.21e-05 | 159 | 119 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 SERBP1 ATRX CCDC18 REV3L KIF3A KHSRP USF3 AFAP1 AKAP9 DNAJC10 MTIF2 DMD ATP2B1 LRIF1 TOP2B PROX1 | 3.69e-05 | 989 | 119 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.56e-05 | 168 | 119 | 7 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 4.67e-05 | 115 | 119 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | SERBP1 MIS18BP1 ESS2 RBM33 NSD2 RPS15A ZCCHC2 KIF3A CCDC47 DDX18 | 5.17e-05 | 376 | 119 | 10 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | FILIP1 MYH8 MYH11 NPY6R WNT2 IRAG1 COL14A1 ALDH1B1 TNNT1 VCL | 6.71e-05 | 388 | 119 | 10 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DCAF1 BDP1 SERBP1 MIS18BP1 IPO8 ANK2 ATRX NSD2 MARS1 IFT81 REV3L AKAP9 PSME4 MTIF2 ETAA1 MACF1 DMD TMCO1 LRIF1 | 7.06e-05 | 1257 | 119 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | CACNA1C FILIP1 MYH8 MYH11 NPY6R WNT2 REV3L CPT1A IRAG1 CCDC47 COL14A1 ALDH1B1 TNNT1 VCL | 9.32e-05 | 761 | 119 | 14 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | FILIP1 MYH8 MYH11 NPY6R CAMK4 WNT2 SCEL REV3L IRAG1 FER1L4 COL14A1 TNNT1 VCL DNM2 | 1.08e-04 | 772 | 119 | 14 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.10e-04 | 84 | 119 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | FILIP1 MYH8 MYH11 NPY6R WNT2 PSMD7 SCEL CPT1A IRAG1 FER1L4 COL14A1 ALDH1B1 TNNT1 VCL | 1.11e-04 | 774 | 119 | 14 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | DCAF1 REPS1 ATRX CAMK4 ZNF226 ADAM12 KHSRP LRRC47 GTF2E1 DNAJC10 SLF2 MTIF2 NR5A2 CCDC68 MACF1 ATP2B1 | 1.20e-04 | 983 | 119 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CACNA1D FILIP1 MYH8 MYH11 KALRN CAMK4 WNT2 REV3L IRAG1 GRHL2 ARHGAP28 TNNT1 VCL DNM2 | 1.70e-04 | 806 | 119 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FILIP1 HIF1A MYH11 GPR37 WNT2 IRAG1 ADAM12 NR5A2 SHE COL14A1 ARHGAP28 TNNT1 ATP2B1 TOP2B | 1.81e-04 | 811 | 119 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | FILIP1 MYH11 IPO8 WNT2 IRAG1 ADAM12 DNAJB14 FAM111A NR5A2 ETAA1 SHE COL14A1 TNNT1 TOP2B | 2.19e-04 | 826 | 119 | 14 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MIS18BP1 KALRN GPR37 IFT81 CCDC18 PTPN13 FAM111A SLF2 LRP1 COL14A1 ARHGAP28 ALDH1B1 TNNT1 ATP2B1 | 2.32e-04 | 831 | 119 | 14 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.68e-04 | 158 | 119 | 6 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_500 | 3.00e-04 | 104 | 119 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 SERBP1 MIS18BP1 REPS1 ATRX CCDC18 ZWINT AKAP9 ETAA1 RIOK2 | 3.12e-04 | 469 | 119 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DCAF1 FILIP1 MIS18BP1 IPO8 ANK2 ATRX NSD2 ATP8A2 IRAG1 AKAP9 PSME4 MTIF2 FER1L4 MACF1 ZMYM1 DMD TMCO1 LRIF1 PROX1 | 3.23e-04 | 1414 | 119 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 3.27e-04 | 164 | 119 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 HIF1A REPS1 ATRX ZWINT GTF2E1 SLF2 MTIF2 MACF1 EMC2 RIOK2 | 3.34e-04 | 564 | 119 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 3.42e-04 | 388 | 119 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TET2 MYH11 RAB8B CCDC18 REV3L ADAM12 ZWINT FAM111A SLFN13 LRP1 COL14A1 ALDH1B1 TNNT1 | 4.20e-04 | 777 | 119 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 MIS18BP1 REPS1 ATRX RBM33 ZNF226 REV3L KIF3A USF3 AFAP1 AKAP9 MACF1 TOP2B | 4.35e-04 | 780 | 119 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.45e-04 | 243 | 119 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | BDP1 CACNA1F MIS18BP1 CAMK4 CCDC18 REV3L GRHL2 AKAP9 CCDC68 LRIF1 | 4.55e-04 | 492 | 119 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 4.75e-04 | 406 | 119 | 9 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DCAF1 BDP1 SERBP1 MIS18BP1 IPO8 ANK2 ATRX NSD2 MARS1 IFT81 REV3L AKAP9 PSME4 MTIF2 ETAA1 MACF1 DMD TMCO1 LRIF1 | 4.76e-04 | 1459 | 119 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_500 | 4.77e-04 | 115 | 119 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.83e-04 | 407 | 119 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_500 | 4.88e-04 | 65 | 119 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | CACNA1D MYH8 MYH11 KALRN GPR37 IFT81 PTPN13 SLF2 LRP1 KCNAB1 ARHGAP28 ALDH1B1 TNNT1 | 5.33e-04 | 797 | 119 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.40e-04 | 251 | 119 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.50e-04 | 330 | 119 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | DCAF1 CACNA1C SERBP1 MIS18BP1 ATRX MARS1 IFT81 FUNDC1 ELL2 AKAP9 SLF2 ETAA1 MACF1 ZMYM1 TMCO1 LRIF1 TOP2B | 5.53e-04 | 1241 | 119 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | KRT1 MYH8 ANK2 CAMK4 SCEL ADAM12 ELL2 NR5A2 KCNAB1 SHE COL14A1 ALDH1B1 TNNT1 | 5.85e-04 | 805 | 119 | 13 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.03e-04 | 184 | 119 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DCAF1 MIS18BP1 ESS2 IPO8 ANK2 ATRX NSD2 ATP8A2 IFT81 REV3L AKAP9 PSME4 ETAA1 DMD TMCO1 TOP2B PROX1 SOS2 | 6.14e-04 | 1370 | 119 | 18 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.73e-04 | 124 | 119 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.40e-04 | 432 | 119 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MIS18BP1 KALRN GPR37 REV3L PTPN13 FAM111A SLF2 LRP1 COL14A1 ARHGAP28 ALDH1B1 TNNT1 ATP2B1 | 7.51e-04 | 827 | 119 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 7.53e-04 | 192 | 119 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 7.57e-04 | 73 | 119 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.78e-04 | 348 | 119 | 8 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.04e-04 | 129 | 119 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 8.28e-04 | 33 | 119 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.30e-04 | 270 | 119 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DCAF1 MIS18BP1 IPO8 ANK2 ATRX NSD2 AKAP9 PSME4 MTIF2 MACF1 ZMYM1 DMD TMCO1 LRIF1 PROX1 | 8.63e-04 | 1060 | 119 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.92e-04 | 132 | 119 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.00e-03 | 203 | 119 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_500 | 1.02e-03 | 136 | 119 | 5 | gudmap_developingGonad_P2_testes_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.05e-03 | 281 | 119 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.17e-03 | 209 | 119 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | MYH11 RBM33 RAB8B NBEA LRRK1 IRAG1 ADAM12 PTPN13 AFAP1 LRP1 ANKRD12 DMD VCL | 1.22e-03 | 872 | 119 | 13 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 MIS18BP1 REPS1 ABR ATRX MARS1 UTP23 ZNF226 REV3L USF3 ELL2 AKAP9 MACF1 LRIF1 | 1.24e-03 | 985 | 119 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.26e-03 | 290 | 119 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.28e-03 | 291 | 119 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.35e-03 | 39 | 119 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 1.35e-03 | 39 | 119 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | DCAF1 CACNA1C SERBP1 MIS18BP1 ATRX MARS1 IFT81 FUNDC1 ELL2 AKAP9 SLF2 NR5A2 ETAA1 MACF1 ZMYM1 TMCO1 LRIF1 TOP2B | 1.35e-03 | 1468 | 119 | 18 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 1.40e-03 | 86 | 119 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 1.40e-03 | 86 | 119 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200 | 1.46e-03 | 40 | 119 | 3 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | CACNA1D MYH8 MYH11 GPR37 IFT81 REV3L PTPN13 SLF2 LRP1 ARHGAP28 ALDH1B1 TNNT1 | 1.49e-03 | 783 | 119 | 12 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | CACNA1C MYH11 KALRN IRAG1 KCNAB1 MACF1 COL14A1 ARHGAP28 DMD VCL | 1.08e-10 | 188 | 121 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CACNA1C CACNA1D FILIP1 KALRN WNT2 ABCA6 LRP1 MACF1 COL14A1 ARHGAP28 | 1.80e-10 | 198 | 121 | 10 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-09 | 192 | 121 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-09 | 193 | 121 | 9 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-09 | 193 | 121 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CACNA1D KALRN WNT2 ADAM12 ABCA6 SLFN13 CCDC68 MACF1 ARHGAP28 | 3.19e-09 | 194 | 121 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-09 | 194 | 121 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-09 | 195 | 121 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-09 | 195 | 121 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.49e-09 | 196 | 121 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.65e-09 | 197 | 121 | 9 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.16e-09 | 200 | 121 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.16e-09 | 200 | 121 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.16e-09 | 200 | 121 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.44e-08 | 161 | 121 | 8 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.91e-08 | 183 | 121 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.91e-08 | 183 | 121 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 187 | 121 | 8 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 187 | 121 | 8 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 187 | 121 | 8 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-08 | 189 | 121 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.02e-08 | 189 | 121 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-08 | 189 | 121 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-08 | 190 | 121 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-08 | 190 | 121 | 8 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-08 | 191 | 121 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.44e-08 | 191 | 121 | 8 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-08 | 191 | 121 | 8 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-08 | 191 | 121 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-08 | 192 | 121 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-08 | 194 | 121 | 8 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-08 | 194 | 121 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.14e-08 | 194 | 121 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-08 | 194 | 121 | 8 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-08 | 195 | 121 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-08 | 195 | 121 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.38e-08 | 195 | 121 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.38e-08 | 195 | 121 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-08 | 195 | 121 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-08 | 195 | 121 | 8 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-08 | 195 | 121 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.91e-08 | 197 | 121 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.91e-08 | 197 | 121 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.91e-08 | 197 | 121 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.18e-08 | 198 | 121 | 8 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-08 | 198 | 121 | 8 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.47e-08 | 199 | 121 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.47e-08 | 199 | 121 | 8 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.76e-08 | 200 | 121 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.49e-07 | 165 | 121 | 7 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.62e-07 | 172 | 121 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.81e-07 | 173 | 121 | 7 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.19e-07 | 175 | 121 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-07 | 180 | 121 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-07 | 180 | 121 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.51e-07 | 181 | 121 | 7 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-07 | 182 | 121 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-07 | 182 | 121 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 8.11e-07 | 187 | 121 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-07 | 187 | 121 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-07 | 187 | 121 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-07 | 188 | 121 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.40e-07 | 188 | 121 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-07 | 189 | 121 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.71e-07 | 189 | 121 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.71e-07 | 189 | 121 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.02e-07 | 190 | 121 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.02e-07 | 190 | 121 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.02e-07 | 190 | 121 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 9.34e-07 | 191 | 121 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.34e-07 | 191 | 121 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-07 | 191 | 121 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-07 | 191 | 121 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 9.34e-07 | 191 | 121 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-07 | 191 | 121 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-07 | 191 | 121 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-07 | 192 | 121 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-07 | 192 | 121 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-07 | 192 | 121 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-06 | 194 | 121 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 194 | 121 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-06 | 194 | 121 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 195 | 121 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 195 | 121 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 195 | 121 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 196 | 121 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| Drug | testosterone enanthate | HIF1A MYH11 SERBP1 ATRX AGGF1 DNAJB14 PSME4 MACF1 COL14A1 ZMYM1 ALDH1B1 ATP2B1 RBM41 PROX1 SOS2 | 3.72e-07 | 575 | 120 | 15 | ctd:C004648 |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 8.72e-07 | 193 | 120 | 9 | 6751_DN | |
| Drug | TTNPB; Up 200; 0.1uM; PC3; HG-U133A | 1.03e-06 | 197 | 120 | 9 | 451_UP | |
| Drug | BAPTA-AM | CACNA1C CACNA1D PLCZ1 HIF1A HYOU1 CAMK4 CAMKV PIK3C3 ATP2B1 VCL | 3.57e-06 | 293 | 120 | 10 | CID000002293 |
| Drug | 3-(1H-pyrrole-2-carboxylate | 4.12e-06 | 233 | 120 | 9 | CID000005114 | |
| Drug | B-C-F | 6.56e-06 | 50 | 120 | 5 | CID000009625 | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 8.30e-06 | 192 | 120 | 8 | 2722_DN | |
| Drug | dihydropyridine | 8.62e-06 | 193 | 120 | 8 | CID000104822 | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 7430_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 7298_UP | |
| Drug | Cinnarizine | 1.17e-05 | 9 | 120 | 3 | DB00568 | |
| Drug | Nimodipine | 1.17e-05 | 9 | 120 | 3 | DB00393 | |
| Drug | Mibefradil | 2.28e-05 | 11 | 120 | 3 | DB01388 | |
| Drug | geldanamycin | 2.77e-05 | 371 | 120 | 10 | ctd:C001277 | |
| Drug | magnesium carbonate | 3.03e-05 | 12 | 120 | 3 | CID000011029 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.48e-05 | 171 | 120 | 7 | 7535_DN | |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; PC3; HT_HG-U133A | 3.61e-05 | 172 | 120 | 7 | 4586_UP | |
| Drug | B0683 | 3.67e-05 | 117 | 120 | 6 | CID006398969 | |
| Drug | ICRF-187 | 4.72e-05 | 38 | 120 | 4 | CID000030623 | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 7.01e-05 | 191 | 120 | 7 | 2861_DN | |
| Drug | Verapamil | 7.61e-05 | 16 | 120 | 3 | DB00661 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 4467_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 6155_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 4685_UP | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 1327_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 5322_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 4316_UP | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; HL60; HT_HG-U133A | 9.35e-05 | 200 | 120 | 7 | 6162_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; PC3; HT_HG-U133A | 9.35e-05 | 200 | 120 | 7 | 6617_UP | |
| Disease | Timothy syndrome (implicated_via_orthology) | 2.42e-07 | 4 | 117 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Headache | 5.69e-06 | 64 | 117 | 5 | HP_0002315 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.25e-05 | 36 | 117 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 9.30e-05 | 4 | 117 | 2 | DOID:0111167 (implicated_via_orthology) | |
| Disease | Brugada Syndrome (disorder) | 1.16e-04 | 24 | 117 | 3 | C1142166 | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 1.55e-04 | 5 | 117 | 2 | DOID:0060247 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 2.52e-04 | 31 | 117 | 3 | EFO_0010820 | |
| Disease | emphysema imaging measurement | 2.97e-04 | 146 | 117 | 5 | EFO_0007626 | |
| Disease | twisted gastrulation protein homolog 1 measurement | 4.30e-04 | 8 | 117 | 2 | EFO_0803205 | |
| Disease | Colorectal Carcinoma | 4.95e-04 | 702 | 117 | 10 | C0009402 | |
| Disease | migraine disorder | 5.69e-04 | 357 | 117 | 7 | MONDO_0005277 | |
| Disease | Pancreatic Neoplasm | 6.87e-04 | 100 | 117 | 4 | C0030297 | |
| Disease | Odontome | 6.87e-04 | 10 | 117 | 2 | C0524730 | |
| Disease | Tooth Abnormalities | 6.87e-04 | 10 | 117 | 2 | C0040427 | |
| Disease | Malignant neoplasm of pancreas | 7.40e-04 | 102 | 117 | 4 | C0346647 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 7.64e-04 | 45 | 117 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | calcium measurement | 9.11e-04 | 628 | 117 | 9 | EFO_0004838 | |
| Disease | intraocular pressure measurement | 9.81e-04 | 509 | 117 | 8 | EFO_0004695 | |
| Disease | pain | 1.13e-03 | 196 | 117 | 5 | EFO_0003843 | |
| Disease | Hypertrophic Cardiomyopathy | 1.52e-03 | 57 | 117 | 3 | C0007194 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.58e-03 | 15 | 117 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.67e-03 | 127 | 117 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Romano-Ward Syndrome | 1.80e-03 | 16 | 117 | 2 | C0035828 | |
| Disease | cervical artery dissection | 2.04e-03 | 17 | 117 | 2 | EFO_1000059 | |
| Disease | Intellectual Disability | 2.08e-03 | 447 | 117 | 7 | C3714756 | |
| Disease | corneal resistance factor | 2.18e-03 | 451 | 117 | 7 | EFO_0010067 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.32e-03 | 139 | 117 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | receptive language perception | 2.55e-03 | 19 | 117 | 2 | EFO_0005686 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.74e-03 | 70 | 117 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.74e-03 | 70 | 117 | 3 | C3241937 | |
| Disease | corneal hysteresis | 2.83e-03 | 20 | 117 | 2 | EFO_0010066 | |
| Disease | Manic Disorder | 2.85e-03 | 71 | 117 | 3 | C0024713 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.85e-03 | 71 | 117 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 2.88e-03 | 243 | 117 | 5 | C1269683 | |
| Disease | Antimigraine preparation use measurement | 3.12e-03 | 21 | 117 | 2 | EFO_0009939 | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 3.12e-03 | 21 | 117 | 2 | DOID:0060036 (implicated_via_orthology) | |
| Disease | aortic measurement | 3.31e-03 | 251 | 117 | 5 | EFO_0020865 | |
| Disease | Manic | 3.72e-03 | 78 | 117 | 3 | C0338831 | |
| Disease | Unipolar Depression | 3.78e-03 | 259 | 117 | 5 | C0041696 | |
| Disease | Depression, Bipolar | 3.86e-03 | 79 | 117 | 3 | C0005587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IQKEKANKGQSRAIE | 391 | Q12979 | |
| QKKRRRKKQDGANEL | 461 | A6H8Y1 | |
| EAGKAKLAQFRQRKA | 11 | Q99996 | |
| ARLQKDGVNQKDKNS | 226 | O00472 | |
| NDIQREKRANKGSKA | 796 | P11274 | |
| GKNRVEADAKRLQTK | 556 | Q8N556 | |
| LERTVEKAKQRKVGN | 336 | P30837 | |
| EFQGKEAIRIRNVKK | 471 | Q8N139 | |
| KIQEDRKAQADKGTQ | 881 | Q96L96 | |
| RGKNKQSLDAVEKAA | 401 | P50416 | |
| EFQRQGKDLEKVKQR | 226 | O43184 | |
| KILQRGRNEDNKKSD | 76 | Q8N302 | |
| KLQNLEGKKREQAER | 291 | Q8N6H7 | |
| KKKEELNAVRRQAEG | 1921 | P11532 | |
| SSRQKDKVNKRNERG | 171 | Q6UB98 | |
| GQFEEQQKRLEKRKD | 1481 | Q9P1Z9 | |
| GLKNNLKEQDKRIEN | 266 | Q9H2F9 | |
| KKQDGAIENRNKAKA | 311 | P20020 | |
| DNAVNKKKTIVLRNG | 146 | Q9NTI2 | |
| KQKELRRQQQAGARK | 806 | Q96EV2 | |
| VIEFGKNKKQRSNLQ | 381 | Q96IZ5 | |
| NDKRQVSKERGEKLA | 126 | P61006 | |
| NDKRQVSKERGEKLA | 126 | Q92930 | |
| KALQKRVEDEQKGRS | 1771 | Q01484 | |
| AGKQLRKESQKDRKN | 66 | Q8NC51 | |
| KAKARGDFQKQREKQ | 381 | O60840 | |
| KEKQRLQNIFATGKD | 121 | Q9BZE7 | |
| KNKSAKQGDRENFRK | 266 | Q9Y4B6 | |
| KQGDRENFRKAKQKL | 271 | Q9Y4B6 | |
| QQKKIAGRQEKGSQD | 2396 | Q8NEZ4 | |
| EQLRAGEKNREKTKQ | 476 | Q6P0N0 | |
| QNGKRGDADQKQTIK | 946 | Q6P0N0 | |
| VKEGERKQQNFDKKR | 616 | Q5T3J3 | |
| QDKVRKNKDAVRRPQ | 156 | P46199 | |
| RNQLGKNEDGLKTKR | 506 | Q38SD2 | |
| DTAQKKLQEFNARRK | 311 | Q16566 | |
| RNGLVKKGKEQNTQR | 151 | Q16665 | |
| KERIVSEEGRKQQNK | 326 | Q14722 | |
| EEQRKQKKRQSVSGL | 421 | Q8N1G4 | |
| QLKDIKVFNRDRQKG | 2141 | Q07954 | |
| NEKRKEKNIKRGGNR | 46 | P52272 | |
| EREAQEAQAGKKKRK | 1661 | A9Z1Z3 | |
| FRLNREGKQKADKNR | 396 | Q96A33 | |
| EGKQKADKNRARVEE | 401 | Q96A33 | |
| KGLADRKQNDQRKVS | 246 | Q9Y6F6 | |
| NEQKRNAEAVKGLRK | 1831 | P13535 | |
| QRGENALKDAKNKLN | 431 | P04264 | |
| QRKIDENENNGVLKK | 361 | Q5TAQ9 | |
| ENGQKPENKARRNRK | 156 | O96028 | |
| IKINKGKRFQQAVDA | 71 | Q49A26 | |
| RRLNSGKADGNIKKQ | 1776 | O60229 | |
| LKRKEKRRQQQEKGE | 91 | Q9BRP8 | |
| VDLNVNSNEGKQKKR | 621 | Q9NVP1 | |
| RAKNIKNKARINEDP | 341 | Q9Y496 | |
| NRSQKDIEGKKDIRA | 236 | P50570 | |
| AKQEAERALKQARKG | 106 | Q9UI10 | |
| KAKQEQRQKIVQAEG | 216 | Q99623 | |
| KEQAAKAERRKQQLA | 931 | Q27J81 | |
| RKKNVDQAIKNGQAL | 5506 | Q9UPN3 | |
| GAKLTQQQDIRKDSK | 646 | Q9NY74 | |
| KKENEGRLNENKRIN | 246 | Q99463 | |
| ERQALQKQALQEKGK | 71 | P27469 | |
| NEAAAKNRAKKQEAL | 361 | Q96DF8 | |
| QGRNVKSRKLKEIFN | 1691 | P46100 | |
| LFNEQRKGQRAKDVR | 286 | Q9Y4L1 | |
| KNTAEQENLGKKLRE | 606 | Q8WYA0 | |
| RDEERKQNRKKGKGQ | 426 | Q6ISB3 | |
| KAEKACTRGNKRQIQ | 471 | O15354 | |
| QKRDGRKVRKAAKNE | 56 | Q8NCB2 | |
| KARGDFQKLREKQQL | 416 | Q13936 | |
| RQLKEENNNGKEKLR | 306 | Q5T9S5 | |
| AGNREKAQRFLQKAE | 21 | Q8TBM8 | |
| LQNGKKFDSSRDRNK | 31 | P68106 | |
| AQGQFRIKDLEKRKD | 111 | Q05707 | |
| RQIKKRANKAAPEIN | 111 | Q8IVP5 | |
| GQRAKKCQERVQSKK | 491 | Q96PZ2 | |
| NQGQDSLKKRLQAKV | 31 | Q96DS6 | |
| RKIAIRKAQGKNVEA | 126 | Q15006 | |
| RKAQGKNVEAIRELN | 131 | Q15006 | |
| SEKLETLRNQGKRNK | 776 | Q8IXB1 | |
| LGEENRKKLQKTQRD | 26 | Q68D06 | |
| AKARGDFQKLREKQQ | 416 | Q01668 | |
| LQQARRDAERQGKKA | 166 | P48444 | |
| LTKKGKNEDNRRKVN | 561 | Q12923 | |
| RRTVAEAKKKIEQQG | 1001 | O15397 | |
| RALKQQKKALIRANG | 176 | O00482 | |
| KKIQNDAGVRIQFKQ | 346 | Q92945 | |
| RKQLRSVLNNLKGDK | 56 | P29083 | |
| EQGLVKNTEQSRRKK | 181 | Q9BRU9 | |
| VKAEQKRGKRQTGRE | 166 | P13805 | |
| VGKDKKAIQASIRRN | 741 | Q96D71 | |
| IAKIIRRKKQAQANG | 731 | Q07890 | |
| KRNDKREVKVAQLAG | 756 | Q02880 | |
| SAGRQQKKKIERQEE | 111 | Q9UM00 | |
| QEERKVDGLNKNFKV | 521 | Q7Z7B0 | |
| KQIFKDNDRLKQGRI | 41 | Q86YW0 | |
| INNKIANRDAEKKEG | 276 | P51665 | |
| QRQEEENIKKGKKGN | 966 | Q8NFP9 | |
| AENKPKREGNNKERD | 321 | Q92786 | |
| RESGNRKKKNERLQA | 561 | Q8NEB9 | |
| RKKKNERLQALLGDN | 566 | Q8NEB9 | |
| NDRDRGKTNADSKKQ | 186 | Q8IX21 | |
| RAARNKAEKQKRDLG | 1131 | P35749 | |
| QAEKGNARVKQLKRQ | 1871 | P35749 | |
| KIKKTDNRLNSRING | 586 | Q9C0B9 | |
| RKEVAKLQEKRGNKA | 376 | O94762 | |
| LKSINNAEKRGKRQV | 11 | P62244 | |
| VNKEEDDKNAQGRKR | 1271 | Q8N2E2 | |
| KLGNLKQQAEQERDK | 191 | O95229 | |
| NRAGRKAVKRFLKQE | 191 | P09544 | |
| RNKRNQTNKLVDDGK | 1191 | O60673 | |
| QEQRKARKEALEKLG | 341 | Q9BW04 | |
| QLKRNKTEKVKGRDN | 361 | Q9P2N2 | |
| KNNDIQKHQGRAKRR | 56 | Q6ZQQ2 | |
| DKNEKGRQNLESVAK | 321 | O95171 | |
| KNSKNQGIEEALKNR | 216 | P18206 | |
| ERQKQEKKAQGRKLS | 766 | Q4KMP7 | |
| GNNEQAEEIKKLRKQ | 81 | Q68DE3 | |
| KEGIKRQQEKNADAL | 1126 | Q14997 | |
| KQQKSAVRRRLQKGE | 511 | Q9BVS4 | |
| DKRDARNKLIKNQLG | 171 | Q96SE7 | |
| NRGGKNIRESTQEKK | 786 | Q9NYT6 | |
| QKRRKIQKSVDLGNS | 936 | Q5SVZ6 | |
| RLIKVDTQEKNGKSN | 146 | Q5VZ18 | |
| KLKQDQKANGERRNF | 111 | Q6N021 | |
| KQGNIVRELKAQKAD | 851 | P56192 | |
| KANNEKQKAERGLEV | 111 | A6NN73 | |
| ANKFTGKNQEIIRNK | 666 | O75096 |